Page last updated: 2024-10-26

racemetirosine and Syndrome

racemetirosine has been researched along with Syndrome in 3 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Syndrome: A characteristic symptom complex.

Research Excerpts

ExcerptRelevanceReference
"He had a negative evaluation for malignant hyperthermia (MH), and we suggest that NMS differs from MH."1.26Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. ( Burke, RE; Fahn, S; Louis, K; Mayeux, R; Weinberg, H; Willner, JH, 1981)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Staedtke, V1
Bai, RY1
Kim, K1
Darvas, M1
Davila, ML1
Riggins, GJ1
Rothman, PB1
Papadopoulos, N1
Kinzler, KW1
Vogelstein, B1
Zhou, S1
Burke, RE1
Fahn, S1
Mayeux, R1
Weinberg, H1
Louis, K1
Willner, JH1
Jacquet, Y1

Other Studies

3 other studies available for racemetirosine and Syndrome

ArticleYear
Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.
    Nature, 2018, Volume: 564, Issue:7735

    Topics: alpha-Methyltyrosine; Animals; Atrial Natriuretic Factor; Catecholamines; CD3 Complex; Cytokines; Ep

2018
Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.
    Neurology, 1981, Volume: 31, Issue:8

    Topics: Adolescent; Adult; alpha-Methyltyrosine; Antipsychotic Agents; Child; Dopamine; Dystonia; Female; Fe

1981
A dystonia-like syndrome after neuropeptide (MSH/ACTH) stimulation of the rat locus ceruleus.
    Advances in neurology, 1988, Volume: 50

    Topics: Adrenocorticotropic Hormone; alpha-Methyltyrosine; Animals; Dose-Response Relationship, Drug; Dyston

1988